Getting the Math Right: The Growing Movement to Improve How Medicines Are Valued Will Take Center Stage at ISPOR 2024 ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Leading health economists will gather in Atlanta on May 5-8 for a meeting of the Professional Society for Health Economics and Outcomes Research (ISPOR),...

Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional Budget Office to Update its Drug R&D Policy Impact Model WASHINGTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- More than 350 biotech investors, executives, and economists today called on the Congressional Budget Office (CBO) to update how it assesses the impact...

Innovative Medicines Provide Greater Value to Patients and Society than Previously Calculated New report finds critical flaws in drug pricing math used to deny patient care Traditional cost-effectiveness math omits quantifiable values recommended by leading health economists WASHINGTON,...